Synergistic Innovative Therapies in Dermatology: Integrating Platelet Derivatives, Biomaterials, and Exogenous Bioactive Substances for Enhancing Skin Repair and Regeneration

The integration of platelet-rich products with biomaterials and exogenous bioactive substances shows potential in improving treatment outcomes for dermatological conditions such as chronic wounds, burns, scars, and skin aging. However, the document highlights the necessity for careful selection of biomaterials and platelet-rich products, as well as the importance of standardized methodologies. It calls for large-scale randomized controlled trials and long-term follow-up studies to conclusively determine the clinical benefits of these combined therapies in dermatology.